El NOBLE Registry – Una colaboración internacional para el desarrollo de imágenes SPECT iPSMA para el cáncer de próstata
21 avr. 2021 00h59 HE
|
Telix Pharmaceuticals Limited
BRUSELAS, Bélgica y MELBOURNE, Australia., April 20, 2021 (GLOBE NEWSWIRE) -- La Oncidium Foundation, una organización sin fines de lucro creada para promover y apoyar el desarrollo de...
The NOBLE Registry – An International Collaboration to Develop iPSMA SPECT Imaging for Prostate Cancer
20 avr. 2021 10h32 HE
|
Telix Pharmaceuticals Limited
BRUSSELS, Belgium and MELBOURNE, Australia, April 20, 2021 (GLOBE NEWSWIRE) -- The Oncidium Foundation, a non-profit organisation created to promote and support the development of...
Telix Pharmaceuticals and Grand River Aseptic Manufacturing Complete Agreement for Commercial Manufacturing of Illuccix®
30 mars 2021 18h02 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, March 30, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces today that it has completed an agreement with...
Czech Republic First European Country to Grant National Authorisation for the Use of Telix’s Prostate Cancer Imaging Product
16 févr. 2021 01h05 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces today that the Ministry of Health of the...
First US Patients Dosed in Phase III ZIRCON Trial of Renal Cancer Imaging Product
24 janv. 2021 17h55 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Jan. 24, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that the first patients have been dosed in...
Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine
29 nov. 2020 21h07 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and BAAR, Switzerland, Nov. 29, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces it has entered into an agreement with Scintec...
Telix Pharmaceuticals 及 China Grand Pharma 宣佈為大中華區市場提供策略許可及商業合作夥伴關係
03 nov. 2020 03h01 HE
|
Telix Pharmaceuticals Limited
澳洲墨爾本與香港, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited（ASX: TLX、「Telix」、「公司」）宣佈已與中國大型製藥及醫療保健控股有限公司（「中國遠大醫藥」）為 Telix 的目標產品組合進行策略許可及商業合作。 Telix 任命「中國遠大醫藥」作為大中華市場（「地區」）1...
Telix Pharmaceuticals与中国远大医药（China Grand Pharma）宣布面向大中华市场的战略许可及商业合作伙伴关系
03 nov. 2020 03h01 HE
|
Telix Pharmaceuticals Limited
澳大利亚墨尔本和香港, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited（ASX: TLX，以下称“Telix”或该“公司”) 宣布就Telix的分子靶向辐射（MTR）产品组合与中国远大医药健康控股有限（“远大医药”）签订战略许可和商业合作伙伴关系。 ...
Telix Pharmaceuticals and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market
01 nov. 2020 23h11 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and HONG KONG, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces it has entered into a strategic licence and...
First Patients Dosed in Phase III ZIRCON Trial of Renal Cancer Imaging Product in Turkey
22 oct. 2020 01h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and ISTANBUL, Turkey, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) and Eczacıbaşı-Monrol Nuclear Products Co. (‘Eczacıbaşı...